Clinical trial
Postmenopausal Estrogen/Progestin Interventions (PEPI)
NCT00000466 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00000466 |
|---|---|
| Title | Postmenopausal Estrogen/Progestin Interventions (PEPI) |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Collaborators | National Institute on Aging (NIA) NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Eunice… |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bone Diseases, Cardiovascular Diseases, Coronary Disease, Diabetes Mellitus, Heart Diseases, Hypercholesterolemia, Hypertension, Myocardial Ischemia, Osteoporosis, Thrombosis and 1 more |
| Intervention type | Drug |
| Interventions | estrogens, conjugated, medroxyprogesterone, progesterone, estrogen replacement therapy |
| Start date | Sep 1, 1987 |
| Completion | Oct 1, 2000 |
| First posted | Oct 28, 1999 |
| Last update posted | May 13, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: